115 related articles for article (PubMed ID: 2787408)
1. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations.
Bertrand R; Jolivet J
J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and in vitro studies of l-leucovorin. Comparison with the d and d,l-leucovorin.
Zittoun J
Ann Oncol; 1993; 4 Suppl 2():1-5. PubMed ID: 8353099
[TBL] [Abstract][Full Text] [Related]
3. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
Zhang ZG; Rustum YM
Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
[TBL] [Abstract][Full Text] [Related]
4. Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil.
Zittoun J; Marquet J; Pilorget JJ; Tonetti C; De Gialluly E
Br J Cancer; 1991 Jun; 63(6):885-8. PubMed ID: 2069845
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
Schilsky RL; Ratain MJ
J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
[TBL] [Abstract][Full Text] [Related]
6. Cellular interactions between the natural and unnatural isomers of 5-formyltetrahydrofolate.
Jolivet J; Bertrand R
Adv Exp Med Biol; 1993; 339():23-30; discussion 41-2. PubMed ID: 8178719
[No Abstract] [Full Text] [Related]
7. Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.
Patel R; Newman EM; Villacorte DG; Sato JK; Reaman GH; Finklestein JZ; Krailo MD; Hammond GD; Holcenberg JS
Cancer Res; 1991 Sep; 51(18):4871-5. PubMed ID: 1893377
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity of orally administered unnatural isomers, [6R]-5-formyltetrahydrofolate and [6S]-5,10-methenyltetrahydrofolate, in humans.
Baggott JE; Tamura T
Biochim Biophys Acta; 1999 Oct; 1472(1-2):323-32. PubMed ID: 10572954
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.
Lee PP; Schilsky RL
Cancer Chemother Pharmacol; 1990; 26(4):273-7. PubMed ID: 2114950
[TBL] [Abstract][Full Text] [Related]
10. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.
Romanini A; Lin JT; Niedzwiecki D; Bunni M; Priest DG; Bertino JR
Cancer Res; 1991 Feb; 51(3):789-93. PubMed ID: 1988119
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a chiral matrix. Resolution of (6R,S)-N5-formyltetrahydrofolate.
Mullin RJ; Duch DS
J Chromatogr; 1991 Aug; 555(1-2):254-9. PubMed ID: 1783627
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
Zhang ZG; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
Straw JA; Newman EM
Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
[No Abstract] [Full Text] [Related]
15. Biomodulation of 5-Fu cytotoxicity by folinic acid and its stereoisomers: in vitro experiments with different cell lines of prostatic cancer.
Breul J; Jakse G; Hartung R
Urol Res; 1995; 23(3):163-7. PubMed ID: 7483142
[TBL] [Abstract][Full Text] [Related]
16. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
Romanini A; Li WW; Colofiore JR; Bertino JR
J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
[TBL] [Abstract][Full Text] [Related]
17. Combination of reduced folates with methotrexate or 5-fluorouracil. Comparison between 5-formyltetrahydrofolate (folinic acid) and 5-methyltetrahydrofolate in vitro activities.
Etienne MC; Fischel JL; Formento P; Schneider M; Guillot T; Bardon M; Milano G
Biochem Pharmacol; 1993 Nov; 46(10):1767-74. PubMed ID: 8250962
[TBL] [Abstract][Full Text] [Related]
18. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion.
Newman EM; Straw JA; Doroshow JH
Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149
[TBL] [Abstract][Full Text] [Related]
20. Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography.
Choi KE; Schilsky RL
Anal Biochem; 1988 Feb; 168(2):398-404. PubMed ID: 2834981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
